Delirium dilemma.
With understanding of diagnostic criteria as well as predisposing and precipitating factors, clinicians can impact the morbidity and mortality of delirium.
Short
Marintha R
MR
UK HealthCare, Lexington, KY 40536-0293, USA.
Winstead
P Shane
PS
D000975:Antioxidants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D003693:Delirium / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D006220:Haloperidol / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008550:Melatonin / Q000378:metabolism / Q000627:therapeutic use; D000077152:Olanzapine; D012307:Risk Factors
D000975:Antioxidants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D006220:Haloperidol; D008550:Melatonin; D000077152:Olanzapine